DYRK1A aggravates β cell dysfunction and apoptosis by promoting the phosphorylation and degradation of IRS2

Area of Science:

• Molecular Biology
• Endocrinology
• Neuroscience

Background:

• Dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A (DYRK1A) is implicated in Alzheimer's disease pathogenesis.
• Islet beta cell dysfunction is a hallmark of diabetes mellitus.

Purpose of the Study:

• To investigate the role of DYRK1A in islet beta cell dysfunction and apoptosis.
• To explore the molecular mechanisms by which DYRK1A affects beta cell function.

Main Methods:

• Utilized APP_swe/PS1_ΔE9 transgenic mouse models.
• Assessed DYRK1A expression in hippocampus and pancreatic islets.
• Examined the interaction between DYRK1A and insulin receptor substrate-2 (IRS2).
• Investigated the impact of DYRK1A overexpression on beta cell apoptosis.

Main Results:

• DYRK1A expression was significantly elevated in the hippocampus and pancreatic islets of transgenic mice.
• Overexpression of DYRK1A aggravated beta cell apoptosis.
• DYRK1A directly interacted with IRS2, promoting its phosphorylation and subsequent proteasomal degradation.
• DYRK1A promoted beta cell dysfunction and apoptosis via IRS2 degradation.

Conclusions:

• DYRK1A plays a critical role in beta cell dysfunction and apoptosis.
• The DYRK1A-IRS2 interaction pathway contributes to diabetes pathogenesis.
• DYRK1A represents a potential therapeutic target for managing diabetes mellitus.